Trials / Completed
CompletedNCT00272688
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
Continuous Delivery of Levodopa/Carbidopa (Duodopa) in Patients With Advanced Idiopathic Parkinsons Disease - a Health Economic Evaluation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University Hospital, Akershus · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
An open, observational health economic study to estimate marginal cost and health consequences of replacing conventional Parkinsons disease therapy with intraduodenal levodopa administered continuously
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levodopa (drug), intraduodenal administration |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2006-01-09
- Last updated
- 2015-12-30
Locations
2 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT00272688. Inclusion in this directory is not an endorsement.